Sleemon Healthy Sleep Technology Co., Ltd. (SHA:603008)
China flag China · Delayed Price · Currency is CNY
8.20
+0.20 (2.50%)
Aug 11, 2026, 3:00 PM CST

SHA:603008 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
134.44241.41322.36428.87237.55558.75
Depreciation & Amortization
244.25244.25258.87251.03243.73179.55
Other Amortization
196.89196.89179.66176.88103.591.61
Loss (Gain) From Sale of Assets
0.010.01-0.121.450.02-0.01
Asset Writedown & Restructuring Costs
32.2632.2623.721.342.344.3
Loss (Gain) From Sale of Investments
14.6614.66-9.31-16.4415.91-44.19
Provision & Write-off of Bad Debts
17.417.421.9851.3817.7954.12
Other Operating Activities
227.4798.3483.9584.83109.33115.42
Change in Accounts Receivable
30.0530.0533.65-24.59350.82-932.47
Change in Inventory
-2.5-2.5137.38157.77-98.07-303.08
Change in Accounts Payable
-8.47-8.47-188.47157.13-99.89998.88
Operating Cash Flow
863.08840.92786.61,253841.29703.61
Operating Cash Flow Growth
29.72%6.91%-37.23%48.95%19.57%-4.92%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-566.15-591.01-361.41-572.71-854.54-492.07
Sale of Property, Plant & Equipment
7.387.186.925.930.061.69
Cash Acquisitions
-15-----
Divestitures
---909064.04
Investment in Securities
-4.73-3.4390.5710-16080.18
Other Investing Activities
-279.718.924.617.949.1211.57
Investing Cash Flow
-858.21-578.35-93.32-243.33-805.64-334.59

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-3,9263,6422,6352,3931,944
Total Debt Issued
3,5253,9263,6422,6352,3931,944
Long-Term Debt Repaid
--3,762-3,284-3,335-2,088-1,810
Total Debt Repaid
-3,139-3,762-3,284-3,335-2,088-1,810
Net Debt Issued (Repaid)
385.78164.43357.44-699.45305.11134.81
Issuance of Common Stock
----159.82-
Repurchase of Common Stock
-124.49-124.49-79.99-200.02--190
Common Dividends Paid
-364.42-363.6-258.19-91.84-188.84-164.38
Other Financing Activities
-49.71-114.5-80.31228.2-306.85-27.05
Financing Cash Flow
-152.84-438.16-61.05-763.11-30.77-246.62

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-147.96-175.59632.23246.674.88122.4

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
296.93249.91425.19680.4-13.25211.54
Free Cash Flow Growth
-5.92%-41.23%-37.51%---59.91%
Free Cash Flow Margin
3.39%2.83%4.87%7.84%-0.17%2.72%
Free Cash Flow Per Share
0.810.671.121.76-0.040.55
Levered Free Cash Flow
-145.4215.25-6.12697.67-431.17949.07
Unlevered Free Cash Flow
-90.3767.242.63741.57-374.95990.31

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
369.72518.28406.68407.67433.29338.27
Change in Working Capital
-4.29-4.29-94.49273.76111.12-255.94